INDP
Price
$10.97
Change
+$0.44 (+4.18%)
Updated
Jul 1, 04:59 PM (EDT)
Capitalization
6.03M
48 days until earnings call
RVPH
Price
$0.37
Change
-$0.01 (-2.63%)
Updated
Jul 1, 04:59 PM (EDT)
Capitalization
25.92M
48 days until earnings call
Interact to see
Advertisement

INDP vs RVPH

Header iconINDP vs RVPH Comparison
Open Charts INDP vs RVPHBanner chart's image
Indaptus Therapeutics
Price$10.97
Change+$0.44 (+4.18%)
Volume$300
Capitalization6.03M
Reviva Pharmaceuticals Holdings
Price$0.37
Change-$0.01 (-2.63%)
Volume$1.5K
Capitalization25.92M
INDP vs RVPH Comparison Chart in %
Loading...
INDP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RVPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
INDP vs. RVPH commentary
Jul 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INDP is a StrongBuy and RVPH is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 02, 2025
Stock price -- (INDP: $10.53 vs. RVPH: $0.38)
Brand notoriety: INDP and RVPH are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: INDP: 6% vs. RVPH: 295%
Market capitalization -- INDP: $6.03M vs. RVPH: $25.92M
INDP [@Biotechnology] is valued at $6.03M. RVPH’s [@Biotechnology] market capitalization is $25.92M. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INDP’s FA Score shows that 1 FA rating(s) are green whileRVPH’s FA Score has 1 green FA rating(s).

  • INDP’s FA Score: 1 green, 4 red.
  • RVPH’s FA Score: 1 green, 4 red.
According to our system of comparison, INDP is a better buy in the long-term than RVPH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INDP’s TA Score shows that 6 TA indicator(s) are bullish while RVPH’s TA Score has 4 bullish TA indicator(s).

  • INDP’s TA Score: 6 bullish, 3 bearish.
  • RVPH’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, INDP is a better buy in the short-term than RVPH.

Price Growth

INDP (@Biotechnology) experienced а -24.79% price change this week, while RVPH (@Biotechnology) price change was -45.12% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.51%. For the same industry, the average monthly price growth was +32.88%, and the average quarterly price growth was +3.93%.

Reported Earning Dates

INDP is expected to report earnings on Aug 18, 2025.

RVPH is expected to report earnings on Aug 18, 2025.

Industries' Descriptions

@Biotechnology (-0.51% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RVPH($25.9M) has a higher market cap than INDP($6.03M). INDP YTD gains are higher at: -55.341 vs. RVPH (-78.945). INDP has higher annual earnings (EBITDA): -16M vs. RVPH (-28.87M). INDP has less debt than RVPH: INDP (59.5K) vs RVPH (224K). INDP (0) and RVPH (0) have equivalent revenues.
INDPRVPHINDP / RVPH
Capitalization6.03M25.9M23%
EBITDA-16M-28.87M55%
Gain YTD-55.341-78.94570%
P/E RatioN/AN/A-
Revenue00-
Total CashN/A5.29M-
Total Debt59.5K224K27%
FUNDAMENTALS RATINGS
INDP vs RVPH: Fundamental Ratings
INDP
RVPH
OUTLOOK RATING
1..100
9550
VALUATION
overvalued / fair valued / undervalued
1..100
30
Undervalued
93
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
6498
P/E GROWTH RATING
1..100
10011
SEASONALITY SCORE
1..100
23n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

INDP's Valuation (30) in the null industry is somewhat better than the same rating for RVPH (93). This means that INDP’s stock grew somewhat faster than RVPH’s over the last 12 months.

INDP's Profit vs Risk Rating (100) in the null industry is in the same range as RVPH (100). This means that INDP’s stock grew similarly to RVPH’s over the last 12 months.

INDP's SMR Rating (100) in the null industry is in the same range as RVPH (100). This means that INDP’s stock grew similarly to RVPH’s over the last 12 months.

INDP's Price Growth Rating (64) in the null industry is somewhat better than the same rating for RVPH (98). This means that INDP’s stock grew somewhat faster than RVPH’s over the last 12 months.

RVPH's P/E Growth Rating (11) in the null industry is significantly better than the same rating for INDP (100). This means that RVPH’s stock grew significantly faster than INDP’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
INDPRVPH
RSI
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
85%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
80%
Momentum
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
87%
MACD
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 14 days ago
79%
Bullish Trend 23 days ago
82%
Declines
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
73%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
INDP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RVPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AMR112.487.60
+7.25%
Alpha Metallurgical Resources
LSTA2.900.10
+3.54%
Lisata Therapeutics
IMMR7.880.20
+2.60%
Immersion Corp
LAB1.200.01
+0.84%
Standard BioTools
HAL20.38-0.19
-0.92%
Halliburton Company

INDP and

Correlation & Price change

A.I.dvisor indicates that over the last year, INDP has been loosely correlated with UNCY. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if INDP jumps, then UNCY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INDP
1D Price
Change %
INDP100%
-9.54%
UNCY - INDP
53%
Loosely correlated
-29.85%
ALT - INDP
45%
Loosely correlated
+10.57%
CDTX - INDP
40%
Loosely correlated
-1.50%
IMAB - INDP
39%
Loosely correlated
-5.84%
RVPH - INDP
30%
Poorly correlated
+12.92%
More

RVPH and

Correlation & Price change

A.I.dvisor indicates that over the last year, RVPH has been loosely correlated with ALT. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if RVPH jumps, then ALT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RVPH
1D Price
Change %
RVPH100%
+12.92%
ALT - RVPH
50%
Loosely correlated
+10.57%
GYRE - RVPH
30%
Poorly correlated
-0.94%
INM - RVPH
26%
Poorly correlated
-3.85%
PCVX - RVPH
25%
Poorly correlated
-0.21%
ARCT - RVPH
25%
Poorly correlated
-2.40%
More